Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 3, 2006, Pages 346-354

  Conrad, Réka ^a   Remberger, Mats ^a   Cederlund, Kerstin ^a   Hentschke, Patrik ^a   Sundberg, Berit ^a   Ringdén, Olle ^a   Barkholt, Lisbeth ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic stem cell transplantation; Colon cancer; Cytokines; Renal cell cancer; Tumor response

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SANDIMMUM NEORAL; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; OUTCOMES RESEARCH; PROTEIN BLOOD LEVEL; SOLID TUMOR; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR REGRESSION; WHOLE BODY RADIATION;

AGED; CYTOKINES; FEMALE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; RETROSPECTIVE STUDIES; TH1 CELLS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TUMOR BURDEN;

EID: 33244489844     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.10.028     Document Type: Article

References (44)

1. P.L. Weiden N. Flournoy E.D. Thomas et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med 300 1979 1068-1073
2. S. Slavin A. Nagler E. Naparstek et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756-763
3. H.J. Kolb J. Mittermuller C. Clemm et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462-2465
4. K.W. van Besien M. de Lima S.A. Giralt et al. Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect Bone Marrow Transplant 19 1997 977-982
5. L.F. Verdonck H.M. Lokhorst A.W. Dekker et al. Graft-versus-myeloma effect in two cases Lancet 347 1996 800-801
6. M.M. Horowitz R.P. Gale P.M. Sondel et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555-562
7. O. Ringd́n M. Labopin E. Gluckman et al. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute leukemia working party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 18 1996 921-929
8. N.T. Ueno G. Rondon N.Q. Mirza et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer J Clin Oncol 16 1998 986-993
9. B. Eibl H. Schwaighofer D. Nachbaur et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer Blood 88 1996 1501-1508
10. R. Childs A. Chernoff N. Contentin et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation N Engl J Med 343 2000 750-758
11. P. Hentschke L. Barkholt M. Uzunel et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma Bone Marrow Transplant 31 2003 253-261
12. D. Blaise J.O. Bay C. Faucher et al. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors Blood 103 2004 435-441
13. S. Slavin E. Naparstek A. Nagler et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp Hematol 23 1995 1553-1562
14. A.M. Carella G. Beltrami E. Lerma et al. Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer Cancer Treat Res 110 2002 101-112
15. J.O. Bay J. Fleury B. Choufi et al. Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: Results of five patients Bone Marrow Transplant 30 2002 95-102
16. F. Moscardo J.A. Martinez G.F. Sanz et al. Graft-versus-tumour effect in non-small-cell lung cancer after allogeneic peripheral blood stem cell transplantation Br J Haematol 111 2000 708-710
17. M. Bregni A. Dodero J. Peccatori et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer Blood 99 2002 4234-4236
18. H. Zetterquist P. Hentschke A. Thorne et al. A graft-versus-colonic cancer effect of allogeneic stem cell transplantation Bone Marrow Transplant 28 2001 1161-1166
19. J. Peccatori F. Ciceri M. Bernardi et al. Evidence of allogeneic graft-versus-tumor effect in prostate and ovarian cancer Haematologica 87 2002 12-14
20. E. Holler H.J. Kolb A. Moller et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 75 1990 1011-1016
21. A. Velardi P. Varese A. Terenzi et al. Lymphokine production by T-cell clones after human bone marrow transplantation Blood 74 1989 1665-1672
22. M. Remberger M. Jaksch M. Uzunel et al. Serum levels of cytokines correlate to donor chimerism and acute graft-vs-host disease after haematopoietic stem cell transplantation Eur J Haematol 70 2003 384-391
23. O. Olerup H. Zetterquist HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation Tissue Antigens 39 1992 225-235
24. O. Ringdén P. Pihlstedt L. Markling et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients Bone Marrow Transplant 7 1991 221-226
25. O. Ringdén M. Remberger U. Persson et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings Bone Marrow Transplant 15 1995 619-625
26. H. Glucksberg R. Storb A. Fefer et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 18 1974 295-304
27. P. Therasse S.G. Arbuck E.A. Eisenhauer et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205-216
28. L. Barkholt P. Hentschke O. Ringdén Reply to the letter by Hori et al [letter] Bone Marrow Transplant 33 2004 257-258
29. T. Kurokawa K. Fischer H. Bertz et al. In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation Int J Cancer 101 2002 52-60
30. L. Barkholt R. Danielsson B. Calissendorff et al. Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation Transplantation 78 2004 697-703
31. A. Lundqvist R. Childs Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: Current status and future directions J Immunother 28 2005 281-288
32. J.L. Ferrara K.R. Cooke T. Teshima The pathophysiology of acute graft-versus-host disease Int J Hematol 78 2003 181-187
33. M. Bleakley S.R. Riddell Molecules and mechanisms of the graft-versus-leukaemia effect Nat Rev Cancer 4 2004 371-380
34. E.H. Warren S.S. Tykodi M. Murata et al. T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma Cytotherapy 4 2002 441
35. T. Mutis Targeting alloreactive donor T-cells to hematopoietic system-restricted minor histocompatibility antigens to dissect graft-versus-leukemia effects from graft-versus-host disease after allogeneic stem cell transplantation Int J Hematol 78 2003 208-212
36. J.E. Visentainer S.R. Lieber L.B. Persoli et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation Exp Hematol 31 2003 1044-1050
37. G. Dranoff Cytokines in cancer pathogenesis and cancer therapy Nat Rev Cancer 4 2004 11-22
38. D.J. Deehan S.D. Heys W. Simpson et al. Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2 Clin Exp Immunol 95 1994 366-372
39. K.S. Shim K.H. Kim W.S. Han et al. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection Cancer 85 1999 554-561
40. A. Huang J.W. Gilmour N. Imami et al. Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration Clin Exp Immunol 134 2003 270-278
41. B.A. Teicher Malignant cells, directors of the malignant process: Role of transforming growth factor-beta Cancer Metastasis Rev 20 2001 133-143
42. P. Pisa E. Halapi E.K. Pisa et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies Proc Natl Acad Sci U S A 89 1992 7708-7712
43. K.J. Malmberg Effective immunotherapy against cancer: A question of overcoming immune suppression and immune escape? Cancer Immunol Immunother 53 2004 879-892
44. C.K. Min W.Y. Lee D.J. Min et. al. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 28 2001 935-940